SPRAVATO TREATMENT:

Spravato is an FDA approved Ketamine treatment that can help major depression. This cutting-edge, FDA-approved treatment has been shown to provide improved outcomes for patients with chronic depression. Spravato esketamine nasal spray is the only FDA-approved form of ketamine treatment for both depression and suicidal ideation. Spravato can help alleviate ongoing clinical depression when traditional medications haven’t worked. Most common side effect can be dissociation, changes in blood pressure, mild headache and nausea. Patients can start to experience immediate relief of symptoms that continue to improve over time with continued treatment. Research has shown Ketamine to increase BDNF, which is essential for healthy brain function.

1. Safe & effective -can provide relief when other treatments do not work

2. Medically guided - Administered under medical supervision in a calm environmen

3. Covered by Most Insurances - For patients that have failed alternative forms of treatment